JP2012127879A5 - Method of determining the degree of progression of nephropathy and agent for suppressing fibrosis - Google Patents
Method of determining the degree of progression of nephropathy and agent for suppressing fibrosis Download PDFInfo
- Publication number
- JP2012127879A5 JP2012127879A5 JP2010281080A JP2010281080A JP2012127879A5 JP 2012127879 A5 JP2012127879 A5 JP 2012127879A5 JP 2010281080 A JP2010281080 A JP 2010281080A JP 2010281080 A JP2010281080 A JP 2010281080A JP 2012127879 A5 JP2012127879 A5 JP 2012127879A5
- Authority
- JP
- Japan
- Prior art keywords
- nephropathy
- progression
- agent
- determining
- degree
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010281080A JP2012127879A (en) | 2010-12-16 | 2010-12-16 | Method for determining progress of nephropathy, and fibrillation inhibitor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2010281080A JP2012127879A (en) | 2010-12-16 | 2010-12-16 | Method for determining progress of nephropathy, and fibrillation inhibitor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012127879A JP2012127879A (en) | 2012-07-05 |
JP2012127879A5 true JP2012127879A5 (en) | 2014-01-23 |
Family
ID=46645073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2010281080A Pending JP2012127879A (en) | 2010-12-16 | 2010-12-16 | Method for determining progress of nephropathy, and fibrillation inhibitor |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2012127879A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6601707B2 (en) * | 2015-02-15 | 2019-11-06 | 国立大学法人金沢大学 | Fibrosis determination method |
JP7126668B2 (en) * | 2017-08-09 | 2022-08-29 | 国立大学法人金沢大学 | Collagen disease determination method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4381495B2 (en) * | 1998-10-30 | 2009-12-09 | 株式会社三和化学研究所 | MCP-1 receptor antagonist comprising organic germanium compound as active ingredient, and preventive or therapeutic agent for inflammatory disease and organ disorder involving MCP-1 |
JP2000229856A (en) * | 1999-02-08 | 2000-08-22 | Sanwa Kagaku Kenkyusho Co Ltd | Prophylactic or therapeutic agent for onset of arteriosclerotic disease containing organogermanium compound as active ingredient |
JP2003081843A (en) * | 2001-09-10 | 2003-03-19 | Sanwa Kagaku Kenkyusho Co Ltd | Agent for critical prevention and treatment of type ii diabetic nephropathy containing organogermanium compound as active ingredient |
WO2006029173A2 (en) * | 2004-09-08 | 2006-03-16 | Boys Town National Research Hospital | Treatment of glomerular basement membrane disease involving matrix metalloproteinase-12 |
WO2008067559A2 (en) * | 2006-11-30 | 2008-06-05 | University Of Virginia Patent Foundation | Methods for treating and diagnosing fibrotic and fibroproliferative diseases |
JP2008303191A (en) * | 2007-06-11 | 2008-12-18 | Kyoto Univ | Preventing or ameliorating agent for disease relating to dysfunction of fat cell containing organic germanium compound as active component |
-
2010
- 2010-12-16 JP JP2010281080A patent/JP2012127879A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2670866A4 (en) | Biomarkers and methods of use thereof | |
EP2619184A4 (en) | Deubiquitinase inhibitors and methods for use of the same | |
BR112012017441A2 (en) | compounds and methods | |
BR112013016969A2 (en) | apparatus and method | |
CO6821917A2 (en) | Building block and construction method of said block | |
BR112013012059A2 (en) | systems and methods for unoptimized handoff | |
IL232598A0 (en) | Solid state forms of vilazodone and vilazodone hydrochloride | |
BR112012027159A2 (en) | structure and method | |
BR112012028015A2 (en) | apparatus and method | |
BR112014010450A2 (en) | composition and method | |
BR112013011096A2 (en) | relay node and reconnect method | |
FI20115463A (en) | Brake and method of making the brake | |
BR112012012798A2 (en) | codec and terminal capacity negotiation method | |
BR112013003535A2 (en) | foaming method | |
BR112013008982A2 (en) | apparatus including metal foam and methods for using the same downhole | |
BR112013005471A2 (en) | abrasive brush and method | |
DK2661274T3 (en) | COMPOSITIONS AND METHODS OF ALOEPOLYSACCHARIDES | |
BR112014010860A2 (en) | composition and method | |
GB201011275D0 (en) | Support platform and method of construction thereof | |
IL225767A0 (en) | Method of determining cleanliness | |
PT2593127T (en) | Anti-angiogenic agent and method of using such agent | |
JP2012127879A5 (en) | Method of determining the degree of progression of nephropathy and agent for suppressing fibrosis | |
BR112013008812A2 (en) | composition and method | |
BR112012029669A2 (en) | composition and method | |
FI20105730A0 (en) | METHOD FOR MANUFACTURE OF THE C-PRESSURE BODY, C-PRESSURE BODY AND C-PRESSURE |